Form 4 for LUNG Pulmonx Corp
Accepted 2026-03-04 00:00:00 ET · period of report 2026-03-02 · accession 0001804146-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-04 | 2026-03-02 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | S - Sale | $1.43 | -7,732 | 368.6K | -2% | -$11.1K |
| 2026-03-04 | 2026-03-02 | LUNG | Rose Geoffrey Beran | Chief COMMERCIAL Off | A - Grant | $0.00 | +100.0K | 465.7K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | S | D | 2,911 | $1.43 | 365,734 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-02 | A | A | 100,000 | $0.00 | 465,734 | D | — | — | (F5) Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 2, 2026. |
| 3 | Common | Common Stock | 2026-03-02 | S | D | 2,125 | $1.43 | 370,506 | D | — | — | |
| 4 | Common | Common Stock | 2026-03-02 | S | D | 835 | $1.43 | 372,631 | D | — | — | |
| 5 | Common | Common Stock | 2026-03-02 | S | D | 1,861 | $1.43 | 368,645 | D | — | — |